Building on our previous work, this study is a further step in our efforts to showcase the vast potential of metal-containing compounds as antimicrobial agents. By obtaining a considerable amount of data on the in vivo toxicity and efficacy of these non-optimized complexes, we hope to encourage researchers everywhere to conduct more studies into these kinds of compounds and/or submit their compounds for screening to CO-ADD so that we can keep expanding our knowledge on the antimicrobial activity of metal complexes and their potential for clinical development.